ConductScience.org, home

Paper564384

Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast.

Sakai F and 6 others. J Endocrinol, 1978. Cited by 117 papers, by iCite.

Cite this record

ConductScience Library. Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast. Papers, record 564384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/564384

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast.
PubMed
Journal
J Endocrinol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
117
iCite
Relative citation ratio, by iCite
4.63
iCite
Revised in PubMed
2019-07-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sakai FF
2Cheix FF
3Clavel MM
4Colon JJ
5Mayer MM
6Pommatau EE
7Saez SS

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Sex Hormone-Binding GlobulinMajor topic
TamoxifenMajor topic
TranscortinMajor topic
Adult
Aged
Aging
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.

PMIDTitleJournalYearIn PapersSource
36205798Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology.Cell Mol Life Sci2022https://conductscience.org/library/papers/36205798PubMed
32565962Serum concentration of sex hormone-binding globulin in healthy volunteers and patients with breast cancer stratified by sex and age.Oncol Lett2020https://conductscience.org/library/papers/32565962PubMed
22890008Regulation of cortisol bioavailability--effects on hormone measurement and action.Nat Rev Endocrinol2012https://conductscience.org/library/papers/22890008PubMed
8883969Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer.Breast Cancer Res Treat1996https://conductscience.org/library/papers/8883969PubMed
8688341Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer.Br J Cancer1996https://conductscience.org/library/papers/8688341PubMed
7981451Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats.Breast Cancer Res Treat1994https://conductscience.org/library/papers/7981451PubMed
6684948Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.Br J Cancer1983https://conductscience.org/library/papers/6684948PubMed
6540595Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.Br J Cancer1984https://conductscience.org/library/papers/6540595PubMed
6423014Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.Breast Cancer Res Treat1983https://conductscience.org/library/papers/6423014PubMed
6184101Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.Breast Cancer Res Treat1982https://conductscience.org/library/papers/6184101PubMed
2952154The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.Br J Cancer1987https://conductscience.org/library/papers/2952154PubMed
2765377Bone mineral content of women receiving tamoxifen for mastalgia.Br J Cancer1989https://conductscience.org/library/papers/2765377PubMed
2690969Chemoprevention of breast cancer.Breast Cancer Res Treat1989https://conductscience.org/library/papers/2690969PubMed
2679843A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.Br J Cancer1989https://conductscience.org/library/papers/2679843PubMed
2328214Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee study.Br J Cancer1990https://conductscience.org/library/papers/2328214PubMed
1911227Influence of the antioestrogen tamoxifen on normal breast tissue.Br J Cancer1991https://conductscience.org/library/papers/1911227PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
SERPINA6866PubTator's text mininghttps://conductscience.org/library/genes/866NCBI Gene
SHBG6462PubTator's text mininghttps://conductscience.org/library/genes/6462NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/564384

GET https://conductscience.org/api/papers/v1/564384/authors